FDA label 0a0da03d-1038-4b92-8a91-1acd99627e91

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
1c5b6d01-2928-4261-9dda-17732755945a
SPL ID
0a0da03d-1038-4b92-8a91-1acd99627e91
Version
5
Effective date
2021-01-06
Source export date
2026-10-12
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:08:54

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Ask a doctor before use if you have asthma. In rare cases broncho-spasm may occur in asthmatic patients. Temporary burning, stinging, sneezing or increased nasal discharge may occur. If pregnant or breast-feeding, ask a healthcare professional before use. Keep out of reach of children. The use of this dispenser by more than one person may spread infection. If symptoms persist or worsen, a healthcare professional should be consulted. Do not use if known sensitivity to ClearLife™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.